Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 5;13(11):1979.
doi: 10.3390/diagnostics13111979.

Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides

Cosimo Di Raimondo  1 , Paolo Lombardo  2 , Cristiano Tesei  3 , Fabiana Esposito  3 , Federico Meconi  3 , Roberto Secchi  3 , Flavia Lozzi  1 , Alessandro Monopoli  2 , Maria Grazia Narducci  2 , Enrico Scala  2 , Cecilia Angeloni  4 , Alberto De Stefano  5 , Siavash Rahimi  2 , Luca Bianchi  1 , Maria Cantonetti  2
Affiliations

Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides

Cosimo Di Raimondo et al. Diagnostics (Basel). .

Abstract

Background: The neutrophil/lymphocyte ratio (NLR) at baseline has been demonstrated to correlate with higher stages of disease and to be a prognostic factor in numerous cancers. However, its function as a prognostic factor for mycosis fungoides (MF) has not been yet clarified.

Objective: Our work aimed to assess the association of the NLR with different stages of MF and to outline whether higher values of this marker are related to a more aggressive MF.

Methods: We retrospectively calculated the NLRs in 302 MF patients at the moment of diagnosis. The NLR was obtained using the complete blood count values.

Results: The median NLR among patients with early stage disease (low-grade IA-IB-IIA) was 1.88, while the median NLR for patients with high-grade MF (IIB-IIIA-IIIB) was 2.64. Statistical analysis showed positive associations of advanced MF stages with NLRs higher than 2.3.

Conclusions: Our analysis demonstrates that the NLR represents a cheap and easily available parameter functioning as a marker for advanced MF. This might guide physicians in recognizing patients with advanced stages of disease requiring a strict follow-up or an early treatment.

Keywords: CTCL; NLR; lymphoma; mycosis fungoides.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cut-Off Plot.
See this image and copyright information in PMC

References

    1. Bradford P.T., Devesa S.S., Anderson W.F., Toro J.R. Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases. Blood. 2009;113:5064–5073. doi: 10.1182/blood-2008-10-184168. - DOI - PMC - PubMed
    1. Wong H.K., Mishra A., Hake T., Porcu P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Br. J. Haematol. 2011;155:150–166. doi: 10.1111/j.1365-2141.2011.08852.x. - DOI - PMC - PubMed
    1. Willemze R., Cerroni L., Kempf W., Berti E., Facchetti F., Swerdlow S.H., Jaffe E.S. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133:1703–1714. doi: 10.1182/blood-2018-11-881268. - DOI - PMC - PubMed
    1. Alberti Violetti S., Alaibac M., Ardigo M., Baldo A., DI Meo N., Massone C., Onida F., Simontacchi G., Zalaudek I., Pimpinelli N., et al. An expert consensus report on mycosis fungoides in Italy: Epidemiological impact and diagnostic-therapeutic pathway. Ital. J. Dermatol. Venereol. 2021;156:413–421. doi: 10.23736/S2784-8671.20.06668-7. - DOI - PubMed
    1. Skov A.G., Gniadecki R. Delay in the histopathologic diagnosis of mycosis fungoides. Acta Derm. Venereol. 2015;95:472–475. doi: 10.2340/00015555-1971. - DOI - PubMed

LinkOut - more resources